Publication Brief
Our understanding of neuroinflammation and its role in central nervous system (CNS) diseases has significantly advanced. Neuroinflammation is pivotal in both the acute response and long-term recovery from acquired brain injuries like traumatic brain injury (TBI) and stroke, and in the pathology of diseases such as multiple sclerosis (MS). It’s also increasingly recognized as a key factor in neurodegenerative diseases like Alzheimer’s (AD) and Parkinson’s (PD), as well as neuropsychiatric conditions such as depression.
Cytokines, critical proteins involved in cell signaling during inflammation, are emerging as important biomarkers in understanding, diagnosing, and tracking the progression of neurological disorders. Research has consistently demonstrated altered cytokine levels in these diseases, highlighting their diagnostic potential.
This brief showcases a sampling of studies utilizing Simoa® digital immunoassay technology for ultra-sensitive cytokine measurement in neurology research. These studies often combine cytokine analysis with other key biomarkers like neurofilament light chain (NfL), glial fibrillary acidic protein (GFAP), Tau, phosphorylated Tau, and amyloid beta (Aβ).
Related Posts
Mapping the Tau Cascade: New Insights from p-Tau 205 and p-Tau 212 for Disease Staging and Monitoring
NPTX2: A Synaptic Biomarker of Circuit Integrity, Cognitive Resilience, and Neurodegeneration
Neurology
Advancing Translational Neuroscience with the Simoa Mammalian GFAP Assay
Publication Brief Understanding astrocyte biology is essential for advancing translational neuroscience. GFAP has emerged as a leading biomarker of CNS injury, and Simoa® technology now enables its ultra-sensitive detection directly…
Proteomics in Transition: From Discovery to Diagnostic Relevance
Proteomics is moving beyond broad discovery to deliver real-time, clinically meaningful insights. At the forefront is Quanterix’s Simoa® digital immunoassay technology, enabling ultra-sensitive, reproducible detection of low-abundance biomarkers in areas…
Neurology
Beyond Blood: Expanding Simoa Applications in Urine, Saliva, Sweat, and Tears
Publication Brief The Quanterix Simoa® platform, known for ultrasensitive detection in plasma, serum, and CSF, now delivers the same performance in alternative matrices—urine, saliva, sweat, and tears. This publication brief…
Immunology
Simoa® IL-17A Advantage PLUS: Potential Biomarker Applications in Health and Disease
App Note IL-17A is a potent pro-inflammatory cytokine that plays critical roles in inflammatory responses, host defense against infections, and tissue regeneration. This application note delves into the physiological and…
Neurology
Beyond Blood: Tear Fluid as a Window into Biomarker Discovery
While blood and CSF have long dominated biomarker research, tear fluid is emerging as a scientifically relevant, non-invasive matrix for detecting systemic and neurological biomarkers. Produced by lacrimal glands and…
Neurology
Sweat As A Non-Invasive Matrix for Cytokine Detection Using Simoa®
Inflammatory cytokines like IL-6, IL-10, and TNF-α are central to understanding aging, immune dysregulation, and chronic disease. With eccrine glands distributed across the body, sweat offers a non-invasive, physiologically relevant…